Eli Lilly is investing $4.5bn in the Lilly Medicine Foundry for drug production and clinical trial medicines. The facility in Indiana will integrate advanced manufacturing to enhance capabilities, optimize processes, and reduce costs. This initiative will support the development and delivery of new medicines.